Last updated on May 2019

Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL


Brief description of study

This is Phase II / III, Prospective, single arm, Open Label Study to Evaluate Safety and Efficacy of Intravenous Autologous CD19 CAR-T Cells for Relapsed / Refractory B-Acute Lymphoblastic Leukaemia

Clinical Study Identifier: NCT03937544

Find a site near you

Start Over

UKM Medical Centre

Bandar Tun Razak, Malaysia
4.87miles
  Connect »